{"id":72357,"date":"2026-08-12T12:03:11","date_gmt":"2026-08-12T04:03:11","guid":{"rendered":"https:\/\/flcube.com\/?p=72357"},"modified":"2026-08-12T12:03:12","modified_gmt":"2026-08-12T04:03:12","slug":"wantais-9-valent-hpv-vaccine-wins-thailand-approval-chinas-first-and-worlds-second-9vhpv-vaccine-expands-into-southeast-asia","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=72357","title":{"rendered":"Wantai&#8217;s 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China&#8217;s First and World&#8217;s Second 9vHPV Vaccine Expands Into Southeast Asia"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/603392:SHA\">SHA: 603392<\/a>) announced that its <strong>self\u2011developed 9\u2011valent human papillomavirus (HPV) vaccine (Escherichia coli)<\/strong> has been <strong>approved for market launch by the Food and Drug Administration of Thailand<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-approval-overview\" class=\"wp-block-heading\">Approval Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392)<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>9\u2011valent HPV vaccine (Escherichia coli), self\u2011developed<\/td><\/tr><tr><td><strong>Regulatory Agency<\/strong><\/td><td>Food and Drug Administration of Thailand<\/td><\/tr><tr><td><strong>Decision<\/strong><\/td><td>Approved for market launch<\/td><\/tr><tr><td><strong>Target Population<\/strong><\/td><td>Females aged 9 to 45<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>12 Aug 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-product-profile\" class=\"wp-block-heading\">Product Profile<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Global Position:<\/strong> <strong>China&#8217;s first and the world&#8217;s second 9\u2011valent HPV vaccine<\/strong>, breaking the long\u2011standing monopoly of the 9vHPV segment.<\/li>\n\n\n\n<li><strong>Manufacturing Platform:<\/strong> Produced in an <strong>Escherichia coli (E. coli)<\/strong> expression system \u2014 a cost\u2011effective and scalable platform distinguishing it from yeast\u2011based competitors.<\/li>\n\n\n\n<li><strong>Coverage:<\/strong> The vaccine targets <strong>seven high\u2011risk HPV types (16, 18, 31, 33, 45, 52, and 58)<\/strong> and <strong>two low\u2011risk types (6 and 11)<\/strong>, offering protection against <strong>related diseases caused by infection with these HPV strains<\/strong>, including cervical cancer, precancerous lesions, and genital warts.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Southeast Asia Entry:<\/strong> Thailand&#8217;s approval marks a key regulatory milestone for Wantai&#8217;s international expansion, providing a reference market for subsequent registrations across ASEAN.<\/li>\n\n\n\n<li><strong>Price\u2011Driven Access:<\/strong> HPV vaccination coverage in emerging markets remains constrained by the high cost and tight supply of incumbent 9\u2011valent vaccines \u2014 an E. coli\u2011based alternative with scale economics could substantially expand accessibility.<\/li>\n\n\n\n<li><strong>Cervical Cancer Elimination Agenda:<\/strong> The approval aligns with the WHO&#8217;s global cervical cancer elimination strategy, under which countries are accelerating HPV immunization programs for adolescent girls.<\/li>\n\n\n\n<li><strong>Competitive Landscape:<\/strong> With only one other 9\u2011valent HPV vaccine marketed globally, Wantai enters the segment as the second supplier, a structurally significant position as demand continues to outstrip supply in many regions.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding commercialization plans and further international registrations for Wantai&#8217;s 9\u2011valent HPV vaccine. Actual results may differ due to risks including regulatory approvals in other markets, supply ramp\u2011up, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/603392_20260812_KBQM.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 603392_20260812_KBQM.\"><\/object><a id=\"wp-block-file--media-4bdcb32b-b2f2-4ca9-b4a1-1ec87de67b2a\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/603392_20260812_KBQM.pdf\">603392_20260812_KBQM<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/603392_20260812_KBQM.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-4bdcb32b-b2f2-4ca9-b4a1-1ec87de67b2a\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its self\u2011developed 9\u2011valent human&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,11],"tags":[15,1011,12,202],"class_list":["post-72357","post","type-post","status-publish","format-standard","hentry","category-company","category-drug","tag-product-approvals","tag-sha-603392","tag-vaccine","tag-wantai-biological-pharmacy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Wantai&#039;s 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China&#039;s First and World&#039;s Second 9vHPV Vaccine Expands Into Southeast Asia - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its self\u2011developed 9\u2011valent human papillomavirus (HPV) vaccine (Escherichia coli) has been approved for market launch by the Food and Drug Administration of Thailand.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=72357\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wantai&#039;s 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China&#039;s First and World&#039;s Second 9vHPV Vaccine Expands Into Southeast Asia\" \/>\n<meta property=\"og:description\" content=\"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its self\u2011developed 9\u2011valent human papillomavirus (HPV) vaccine (Escherichia coli) has been approved for market launch by the Food and Drug Administration of Thailand.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=72357\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-12T04:03:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-12T04:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72357#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72357\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Wantai&#8217;s 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China&#8217;s First and World&#8217;s Second 9vHPV Vaccine Expands Into Southeast Asia\",\"datePublished\":\"2026-08-12T04:03:11+00:00\",\"dateModified\":\"2026-08-12T04:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72357\"},\"wordCount\":349,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Product approvals\",\"SHA: 603392\",\"Vaccine\",\"Wantai Biological Pharmacy\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72357#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72357\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=72357\",\"name\":\"Wantai's 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China's First and World's Second 9vHPV Vaccine Expands Into Southeast Asia - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-12T04:03:11+00:00\",\"dateModified\":\"2026-08-12T04:03:12+00:00\",\"description\":\"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its self\u2011developed 9\u2011valent human papillomavirus (HPV) vaccine (Escherichia coli) has been approved for market launch by the Food and Drug Administration of Thailand.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72357#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72357\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72357#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wantai&#8217;s 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China&#8217;s First and World&#8217;s Second 9vHPV Vaccine Expands Into Southeast Asia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Wantai's 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China's First and World's Second 9vHPV Vaccine Expands Into Southeast Asia - Insight, China&#039;s Pharmaceutical Industry","description":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its self\u2011developed 9\u2011valent human papillomavirus (HPV) vaccine (Escherichia coli) has been approved for market launch by the Food and Drug Administration of Thailand.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=72357","og_locale":"en_US","og_type":"article","og_title":"Wantai's 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China's First and World's Second 9vHPV Vaccine Expands Into Southeast Asia","og_description":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its self\u2011developed 9\u2011valent human papillomavirus (HPV) vaccine (Escherichia coli) has been approved for market launch by the Food and Drug Administration of Thailand.","og_url":"https:\/\/flcube.com\/?p=72357","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-12T04:03:11+00:00","article_modified_time":"2026-08-12T04:03:12+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=72357#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=72357"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Wantai&#8217;s 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China&#8217;s First and World&#8217;s Second 9vHPV Vaccine Expands Into Southeast Asia","datePublished":"2026-08-12T04:03:11+00:00","dateModified":"2026-08-12T04:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=72357"},"wordCount":349,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Product approvals","SHA: 603392","Vaccine","Wantai Biological Pharmacy"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=72357#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=72357","url":"https:\/\/flcube.com\/?p=72357","name":"Wantai's 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China's First and World's Second 9vHPV Vaccine Expands Into Southeast Asia - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-12T04:03:11+00:00","dateModified":"2026-08-12T04:03:12+00:00","description":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its self\u2011developed 9\u2011valent human papillomavirus (HPV) vaccine (Escherichia coli) has been approved for market launch by the Food and Drug Administration of Thailand.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=72357#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=72357"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=72357#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Wantai&#8217;s 9\u2011Valent HPV Vaccine Wins Thailand Approval \u2013 China&#8217;s First and World&#8217;s Second 9vHPV Vaccine Expands Into Southeast Asia"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=72357"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72357\/revisions"}],"predecessor-version":[{"id":72359,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72357\/revisions\/72359"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=72357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=72357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=72357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}